Literature DB >> 7663758

Obtaining a more resolute teleost growth hormone phylogeny by the introduction of gaps in sequence alignment.

D A Rubin1, R M Dores.   

Abstract

In order to obtain a more resolute phylogeny of teleosts based on growth hormone (GH) sequences, phylogenetic analyses were performed in which deletions (gaps), which appear to be order specific, were upheld to maintain GH's structural information. Sequences were analyzed at 194 amino acid positions. In addition, the two closest genealogically related groups to the teleosts, Amia calva and Acipenser guldenstadti, were used as outgroups. Modified sequence alignments were also analyzed to determine clade stability. Analyses indicated, in the most parsimonious cladogram, that molecular and morphological relationships for the orders of fishes are congruent. With GH molecular sequence data it was possible to resolve all clades at the familial level. Analyses of the primary sequence data indicate that: (a) the halecomorphean and chondrostean GH sequences are the appropriate outgroups for generating the most parsimonious cladogram for teleosts; (b) proper alignment of teleost GH sequence by the inclusion of gaps is necessary for resolution of the Percomorpha; and (c) removal of sequence information by deleting improperly aligned sequence decreases the phylogenetic signal obtained.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663758     DOI: 10.1006/mpev.1995.1013

Source DB:  PubMed          Journal:  Mol Phylogenet Evol        ISSN: 1055-7903            Impact factor:   4.286


  2 in total

1.  The molecular evolution of vertebrate growth hormones: a pattern of near-stasis interrupted by sustained bursts of rapid change.

Authors:  M Wallis
Journal:  J Mol Evol       Date:  1996-08       Impact factor: 2.395

2.  Evolutionary divergence of duplicate copies of the growth hormone gene in suckers (Actinopterygii: catostomidae).

Authors:  Henry L Bart; Paulette C Reneau; Michael H Doosey; Charles D Bell
Journal:  Int J Mol Sci       Date:  2010-03-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.